Literature DB >> 11523937

Enteroaggregative Escherichia coli infection in a rabbit model.

G Kang1, A B Pulimood, M M Mathan, V I Mathan.   

Abstract

Type strains of enteroaggregative Escherichia coli EAEC (17-2, serotype O3:H2; JM 221, serotype O92:H33), isolates from an adult and a child with diarrhoea and an asymptomatic colonised child were used to orally infect adult rabbits. The experimental animals were followed up and sacrificed at defined time periods. Colonisation of both small and large intestine was seen with all strains and isolates used. Isolates from an adult patient with diarrhoea (MP 27) and from an asymptomatic colonised child from the community (KM 1337) were recovered from the small intestine during the first week of infection and subsequently from the large intestine. A total of seven rabbits was infected with MP 27; while colonising the gastrointestinal tract of all seven rabbits, this isolate caused diarrhoea in only one. On ultrastructural examination, the rabbits infected with 17-2 showed invasion of lymphoid follicles. Bacteria were seen in intercellular spaces and within M cells, a finding that has not previously been described. It is clearly possible to produce gut colonisation by oral infection with EAEC in adult rabbits with normal flora.

Entities:  

Mesh:

Year:  2001        PMID: 11523937

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  9 in total

1.  Evidence of rotavirus associated with neonatal lamb diarrhoea in India.

Authors:  S A Wani; M A Bhat; R Nawchoo; Z H Munshi; A S Bach
Journal:  Trop Anim Health Prod       Date:  2004-01       Impact factor: 1.559

2.  The fimbriae of enteroaggregative Escherichia coli induce epithelial inflammation in vitro and in a human intestinal xenograft model.

Authors:  Erik J Boll; Carsten Struve; Anja Sander; Zachary Demma; James P Nataro; Beth A McCormick; Karen A Krogfelt
Journal:  J Infect Dis       Date:  2012-06-21       Impact factor: 5.226

3.  Lymphocytic colitis: a clue to bacterial etiology.

Authors:  Thanaa Ea Helal; Naglaa S Ahmed; Osama Abo El Fotoh
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

4.  Virulence of the Shiga toxin type 2-expressing Escherichia coli O104:H4 German outbreak isolate in two animal models.

Authors:  Tonia Zangari; Angela R Melton-Celsa; Aruna Panda; Nadia Boisen; Mark A Smith; Ivan Tatarov; Louis J De Tolla; James P Nataro; Alison D O'Brien
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

5.  Aggregative Adherence Fimbriae II of Enteroaggregative Escherichia coli Are Required for Adherence and Barrier Disruption during Infection of Human Colonoids.

Authors:  Laura A Gonyar; Rachel M Smith; Jorge A Giron; Nicholas C Zachos; Fernando Ruiz-Perez; James P Nataro
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

6.  A new understanding of enteroaggregative Escherichia coli as an inflammatory pathogen.

Authors:  Erik J Boll; Beth A McCormick
Journal:  Cell Adh Migr       Date:  2012-09-01       Impact factor: 3.405

7.  Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine.

Authors:  Damien Maura; Matthieu Galtier; Chantal Le Bouguénec; Laurent Debarbieux
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

8.  In vivo bioluminescence imaging of Escherichia coli O104:H4 and role of aerobactin during colonization of a mouse model of infection.

Authors:  Alfredo G Torres; Roberto J Cieza; Maricarmen Rojas-Lopez; Carla A Blumentritt; Cristiane S Souza; R Katie Johnston; Nancy Strockbine; James B Kaper; Elena Sbrana; Vsevolod L Popov
Journal:  BMC Microbiol       Date:  2012-06-20       Impact factor: 3.605

9.  Autotransporters but not pAA are critical for rabbit colonization by Shiga toxin-producing Escherichia coli O104:H4.

Authors:  Diana Munera; Jennifer M Ritchie; Stavroula K Hatzios; Rod Bronson; Gang Fang; Eric E Schadt; Brigid M Davis; Matthew K Waldor
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.